Phase 4 Type 2 Diabetes Trial, Recruiting NCT03059069 Sponsor: Yonsei University Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Phase 4 Type 2 Diabetes Trial, Recruiting

NCT03059069
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Type 2 diabetes
  • You are 50 years of age or older
  • Your blood sugar levels are reasonably controlled, with an HbA1c (a measure of average blood sugar over time) of 10.0% or below
  • You have a score between 10 and 29 on the Beck Depression Inventory, which is a standard questionnaire used to measure symptoms of depression (mild to moderate range)
  • If you are able to have children, you are willing and able to use contraception during the trial
  • You understand what the study involves, including the risks and alternatives, and are willing to sign a consent form to take part

Who may not be able to join:

  • You have Type 1 diabetes, a form of diabetes caused by another medical condition, or diabetes that developed during pregnancy
  • You are currently receiving treatment for dementia or taking medication for depression or other mood disorders
  • You have a psychiatric (mental health) condition that is not currently under control
  • You scored 30 or above on the Beck Depression Inventory depression questionnaire
  • You drink heavily or consume large amounts of alcohol regularly
  • You have a long-term liver condition, such as liver scarring (cirrhosis), liver cancer, chronic viral hepatitis, or certain other liver diseases
  • You have a known allergy or sensitivity to the medication being studied or any of its ingredients
  • You have significant kidney problems or reduced kidney function, or you are currently on dialysis
  • Your liver function blood tests show results more than three times above the normal range
  • You have had problems with alcohol or drug misuse in the past 3 months
  • You are a woman who has not yet gone through menopause and are currently pregnant or breastfeeding
  • You have HIV or AIDS
  • You have chronic inflammation of the pancreas (chronic pancreatitis) or pancreatic cancer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
1 June 2016
Est. completion
30 June 2025

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

changes in Hamilton Depression Rating Scale (HDRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov